These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17395706)

  • 1. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
    Balemans W; Van Hul W
    Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP5, Bone Mass Polymorphisms and Skeletal Disorders.
    Littman J; Yang W; Olansen J; Phornphutkul C; Aaron RK
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
    Ai M; Heeger S; Bartels CF; Schelling DK;
    Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lrp5 functions in bone to regulate bone mass.
    Cui Y; Niziolek PJ; MacDonald BT; Zylstra CR; Alenina N; Robinson DR; Zhong Z; Matthes S; Jacobsen CM; Conlon RA; Brommage R; Liu Q; Mseeh F; Powell DR; Yang QM; Zambrowicz B; Gerrits H; Gossen JA; He X; Bader M; Williams BO; Warman ML; Robling AG
    Nat Med; 2011 Jun; 17(6):684-91. PubMed ID: 21602802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.
    Wang X; Zhang H; Hu L; He J; Jiang Q; Ren L; Yu K; Fu M; Li Z; He Z; Zhu J; Wang Y; Jiang Z; Yang G
    Bone; 2024 Oct; 187():117172. PubMed ID: 38909879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.
    Williams BO; Insogna KL
    J Bone Miner Res; 2009 Feb; 24(2):171-8. PubMed ID: 19072724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.
    Foer D; Zhu M; Cardone RL; Simpson C; Sullivan R; Nemiroff S; Lee G; Kibbey RG; Petersen KF; Insogna KL
    Osteoporos Int; 2017 Jun; 28(6):2011-2017. PubMed ID: 28283687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.
    Clément-Lacroix P; Ai M; Morvan F; Roman-Roman S; Vayssière B; Belleville C; Estrera K; Warman ML; Baron R; Rawadi G
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17406-11. PubMed ID: 16293698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loading.
    Zhao L; Shim JW; Dodge TR; Robling AG; Yokota H
    Bone; 2013 May; 54(1):35-43. PubMed ID: 23356985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LRP5 high-bone-mass mutation causes alveolar bone accrual with minor craniofacial alteration.
    Turkkahraman H; Flanagan S; Zhu T; Bellido TM; Yuan X
    J Periodontal Res; 2023 Aug; 58(4):723-732. PubMed ID: 37128744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in WNT1 cause different forms of bone fragility.
    Keupp K; Beleggia F; Kayserili H; Barnes AM; Steiner M; Semler O; Fischer B; Yigit G; Janda CY; Becker J; Breer S; Altunoglu U; Grünhagen J; Krawitz P; Hecht J; Schinke T; Makareeva E; Lausch E; Cankaya T; Caparrós-Martín JA; Lapunzina P; Temtamy S; Aglan M; Zabel B; Eysel P; Koerber F; Leikin S; Garcia KC; Netzer C; Schönau E; Ruiz-Perez VL; Mundlos S; Amling M; Kornak U; Marini J; Wollnik B
    Am J Hum Genet; 2013 Apr; 92(4):565-74. PubMed ID: 23499309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).
    Warden SJ; Robling AG; Haney EM; Turner CH; Bliziotes MM
    Bone; 2010 Jan; 46(1):4-12. PubMed ID: 19591966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRP5 gene polymorphism and cortical bone.
    Lauretani F; Cepollaro C; Bandinelli S; Cherubini A; Gozzini A; Masi L; Falchetti A; Del Monte F; Carbonell-Sala S; Marini F; Tanini A; Corsi AM; Ceda GP; Brandi ML; Ferrucci L
    Aging Clin Exp Res; 2010 Aug; 22(4):281-8. PubMed ID: 21116122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of Wnt signaling for osteoanabolic therapy.
    Yorgan TA; Schinke T
    Mol Cell Ther; 2014; 2():22. PubMed ID: 26056589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5.
    Diegel CR; Kramer I; Moes C; Foxa GE; McDonald MJ; Madaj ZB; Guth S; Liu J; Harris JL; Kneissel M; Williams BO
    Bone Res; 2023 Aug; 11(1):47. PubMed ID: 37612291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lrp5 regulation of bone mass and serotonin synthesis in the gut.
    Kode A; Obri A; Paone R; Kousteni S; Ducy P; Karsenty G
    Nat Med; 2014 Nov; 20(11):1228-9. PubMed ID: 25375916
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of rare low bone mass diseases for osteoporosis genetics.
    Costantini A; Mäkitie O
    Bonekey Rep; 2016; 5():773. PubMed ID: 26793304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular adenosine signaling in bone health and disease.
    Newman H; Varghese S
    Curr Opin Pharmacol; 2023 Jun; 70():102378. PubMed ID: 37044008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family.
    Puente N; Vega AI; Hernandez JL; Fernandez-Luna JL; Riancho JA
    Osteoporos Int; 2022 Nov; 33(11):2445-2448. PubMed ID: 35840698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.